FDA.reportPublic FDA data

acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]

RxCUI
1358853
RxNorm name
acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
Display name
EXAPRIN (Oral Pill)
Full name
acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
Term type
SBD
Status
Active
Strength
110-162-32.4-152 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-07-23 06:56:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin162 MG / 1 EACHaspirinaspirin
acetaminophen110 MG / 1 EACHacetaminophenacetaminophen
caffeine32.4 MG / 1 EACHcaffeinecaffeine
salicylamide152 MG / 1 EACHsalicylamidesalicylamide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
acetaminophen161
caffeine1886
salicylamide9518

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRAPAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]NAMES
RxNorm Nameacetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]NAMES
RxNorm SynonymAPAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]NAMES
RxNorm SynonymExaprin (APAP 110 MG / ASA 162 MG / caffeine 32.4 MG / salicylamide 152 MG) Oral TabletNAMES
TTYSBDATTRIBUTES
RxCUI1358853CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
50332010504rxnav_ndcsyes
50332010507rxnav_ndcsyes
50332010508rxnav_ndcsyes
50332010503rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9fe82229-cc3e-4d79-a448-014fe3d0055bacetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]SBD3EXAPRIN20191130
9fe82229-cc3e-4d79-a448-014fe3d0055bAPAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]SY3EXAPRIN20191130
9fe82229-cc3e-4d79-a448-014fe3d0055bExaprin (APAP 110 MG / ASA 162 MG / caffeine 32.4 MG / salicylamide 152 MG) Oral TabletSY3EXAPRIN20191130
9fe82229-cc3e-4d79-a448-014fe3d0055bEXAPRIN Extra-Strength Pain Reliever 110 MG / 162 MG / 32.4 MG / 152 MG Oral TabletPSN3EXAPRIN20191130

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9fe82229-cc3e-4d79-a448-014fe3d0055bEXAPRINHART Health20191130

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4salicylamide
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD012457SalicylamidesCHEMhas_ingredientsalicylamide
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylamide
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treatsalicylamide
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treatsalicylamide
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moasalicylamide
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pesalicylamide
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH110 MG / 162 MG / 32.4 MG / 152 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESRxCUI1358853
NAMESPrescribable SynonymEXAPRIN Extra-Strength Pain Reliever 110 MG / 162 MG / 32.4 MG / 152 MG Oral Tablet
NAMESRXNAV_STRAPAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
NAMESRxNorm Nameacetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
NAMESRxNorm SynonymAPAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
NAMESRxNorm SynonymExaprin (APAP 110 MG / ASA 162 MG / caffeine 32.4 MG / salicylamide 152 MG) Oral Tablet
SOURCESSourceMicromedex RED BOOK